Basic & Clinical Medicine ›› 2020, Vol. 40 ›› Issue (9): 1195-1200.

• Original Articles • Previous Articles     Next Articles

Predictive research of 5-hydroxytryptamine in severity of severe community-acquired pneumonia

HE Quan1, LIU Dan-yu2,3, YE Jun1, ZHANG Yan-li1, ZHU Hua-dong2, JIANG Cheng-yu1*, XU Jun2*   

  1. 1. Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences CAMS, School of Basic Medicine PUMC, Beijing 100005;
    2. Department of Emergency, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730;
    3. Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China
  • Received:2020-07-12 Revised:2020-07-24 Online:2020-09-05 Published:2020-09-04
  • Contact: *jiang@pumc.edu.cn; xujunfree@126.com

Abstract: Objective To search for potential prognostic markers for severe community-acquired pneumonia (SCAP) using non-targeted metabolomics. Methods Testing plasma samples from 30 healthy people and 68 SCAP patients (all collected from January 2015 to June 2019 at Peking Union Medical College Hospital) by liquid chromatography mass spectrometry (LC-MS). According to clinical prognosis, patients were divided into survive group (n=49) and non-survive group (n=19). OPLS-DA (multivariate statistical analysis) and Kruskal Wallis Test (single variable statistical analysis) were used to identify differential metabolites. Correlation analysis of clinical indicators and prognostic analysis were also used for differential metabolites. Results Totally 3 463 metabolites were detected in healthy people and SCAP patients by LC-MS. Among them, 126 metabolites were screened out by OPLS-DA andKruskal Wallis Test analysis methods. Prognostic analysis showed that the quantity of 5-hydroxytryptamine(5-HT) was significantly different between survive group and non-survive group (P<0.05, AUC>0.75). Correlation analysis of clinical indicators showed that 5-HT was positively correlated with oxygenation index (OI) and negatively correlated with acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ) score. Conclusions The 5-HT as a potential prognostic marker for SCAP, may predict the prognosis of SCAP patients.

Key words: 5-hydroxytryptamine(5-HT), severe community-acquired pneumonia(SCAP), prognostic markers, metabolomics

CLC Number: